Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Program crawled date : 2022 - 09 - 20 save search
NuLegacy Suspends Drilling Program
Published: 2022-09-20 (Crawled : 21:00) - globenewswire.com
NULGF | $0.0086 121.95% 350K
|
Non-Energy Minerals
|
| O: 0.0%
H: 0.0%
C: -13.33%
program
Lomiko announces second round of analytical results from the infill and extension exploration drill program at La Loutre Graphite property, drilling 11.64% Cg over 42.0m at southern end of EV Zone
Published: 2022-09-20 (Crawled : 17:00) - lomiko.com
LMRMF | $0.013 1111.71% 170K
|
Non-Energy Minerals
|
| O: -2.6%
H: 14.33%
C: 14.33%
LTUM | $0.0351 33.16% 410K
|
Mining, Quarrying, and Oil and ...
|
| O: -1.04%
H: 3.83%
C: -0.06%
CRECF | $0.5378 0.15% 12K
|
Process Industries
|
| O: -2.13%
H: 6.52%
C: 0.0%
extension program results
East Bay Customers Support California's Grid During Extreme Heat Wave Through Innovative Program
Published: 2022-09-20 (Crawled : 15:20) - prnewswire.com
RUN | $10.02 -2.43% -2.5% 9.9M
|
Utilities
|
| O: -0.78%
H: 1.19%
C: -6.37%
bay program
VAMPPED Joins IZEA’s Talent Partner Program
Published: 2022-09-20 (Crawled : 14:00) - izea.com
IZEA 4 | $2.565 4.27% 4.09% 56K
|
Technology Services
|
| O: 0.07%
H: 2.36%
C: -4.34%
program
Mondelēz International’s SnackFutures Opens Applications for CoLab 2023 Start-Up Engagement Program
Published: 2022-09-20 (Crawled : 13:20) - globenewswire.com
MDLZ | $71.325 0.81% 0.81% 16M
|
Consumer Non-Durables
|
| O: -0.56%
H: 0.32%
C: -0.48%
program
Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection
Published: 2022-09-20 (Crawled : 12:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: -0.66%
H: 0.44%
C: -0.08%
treatment program infection hiv
MD Anderson Cancer Center Selects ViewRay to Expand MR-Guided Radiation Therapy Program
Published: 2022-09-20 (Crawled : 11:00) - prnewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.7%
H: 0.4%
C: -1.03%
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: -0.27%
H: 12.47%
C: 8.77%
viewray program therapy cancer
Just – Evotec Biologics Awarded Contract from the U.S. Department of Defense Under Accelerated Antibodies Program
Published: 2022-09-20 (Crawled : 09:00) - biospace.com/
EVO | $5.22 -31.77% -46.55% 1.5M
|
Manufacturing
|
| O: -7.91%
H: 3.7%
C: 2.39%
defense program contract
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.